Relative Bradycardia in Typhoid Diagnosis and Management
Relative bradycardia is a useful but non-specific diagnostic predictor for typhoid fever that should prompt blood culture collection in febrile returned travelers, particularly those from South Asia, though it cannot be relied upon alone for diagnosis.
Diagnostic Value of Relative Bradycardia
Relative bradycardia occurs frequently in typhoid fever and serves as a meaningful clinical clue, though its specificity is limited. Among febrile returned travelers, relative bradycardia (using Cunha's criteria) has an adjusted odds ratio of 11.7 for enteric fever diagnosis and appears in 88% of typhoid cases versus 51% of other febrile illnesses 1. The positive likelihood ratio is 1.72, but more importantly, its negative predictive value reaches 92%, meaning its absence makes typhoid less likely 1.
Key Diagnostic Points:
- Relative bradycardia is characteristic of typhoid fever, Legionnaire's disease, and Chlamydia pneumonia - it appears specific to infections caused by organisms that are both gram-negative and intracellular 2
- The finding has no predictive value as an isolated sign for determining infection type, but becomes meaningful when combined with epidemiological factors 2
- Eosinopenia (absolute count of 0/μL) occurs in 63% of typhoid cases versus 38% of other fevers, with similar diagnostic utility 1
Clinical Presentation Context:
Typhoid presents with fever (almost invariable), headache, constipation or diarrhea, dry cough, and non-specific symptoms 3. Notably, diarrhea is uncommon despite gastrointestinal portal of entry 4. Full blood count and liver function tests may show any pattern of abnormality 3. Complications (GI bleeding, perforation, encephalopathy) occur in 10-15% and are more likely after 2 weeks of illness 3.
Diagnostic Approach
When evaluating a febrile patient with relative bradycardia:
Obtain detailed travel history - Typhoid should be considered when fever occurs (with or without diarrhea) in persons with travel to endemic areas, consumption of foods prepared by those with recent endemic exposure, or laboratory exposure to S. Typhi/Paratyphi 4
Geographic risk assessment is critical - Return from South Asia carries an adjusted odds ratio of 21.6 for enteric fever 1. South and Southeast Asia have the highest incidence, with moderate risk in Central/South America, Africa, and Oceania 4
Blood cultures are the gold standard - Highest yield within the first week of symptoms (40-80% sensitivity, potentially higher with modern methods) 3. Obtain blood, stool, and urine cultures before starting antibiotics 4
Bone marrow culture has higher sensitivity than blood culture when blood cultures are negative but suspicion remains high 3
Avoid the Widal test - it lacks sensitivity and specificity and is not recommended 3. Newer rapid serological tests (Typhidot, Tubex) show mixed results 3
Common Pitfall:
Do not rely on vaccination history to exclude typhoid - vaccination provides incomplete protection against typhoid and does not protect against paratyphoid 3.
Management Recommendations
For patients with clinical features of sepsis suspected of having enteric fever, start empiric broad-spectrum antimicrobial therapy immediately after culture collection 4.
Empiric Treatment Strategy:
First-line empiric therapy: Intravenous ceftriaxone 3
- This is now preferred over fluoroquinolones due to widespread resistance
- More than 70% of S. Typhi/Paratyphi isolates from Asia are fluoroquinolone-resistant 3
- All UK isolates in 2006 were sensitive to ceftriaxone 3
Oral alternatives for uncomplicated disease:
- Azithromycin - suitable when fluoroquinolone resistance confirmed; resistance currently rare; relapse rate <3% 3
- Fluoroquinolones (ciprofloxacin) - only if isolate is sensitive to nalidixic acid on disc testing; average fever clearance <4 days, cure rates >96% when sensitive 3
- Cefixime - reported treatment failure rates of 4-37.6%, making it less reliable 3
Treatment Duration and Monitoring:
- Continue treatment for 14 days to reduce relapse risk 3
- Relapse rates: fluoroquinolones and ceftriaxone <8%, azithromycin <3% 3
- Consider steroids in severe cases 3
- Early treatment improves outcomes - intestinal perforation and death were more common in pre-antibiotic era, and patients treated early have better outcomes than those treated later 4
Antibiotic Sensitivity Testing Caveat:
Ciprofloxacin disc testing is unreliable for determining fluoroquinolone sensitivity - the isolate should only be considered sensitive if also sensitive to nalidixic acid on disc testing 3.
Emerging Resistance Concerns:
Extensively drug-resistant (XDR) typhoid strains are spreading globally, particularly from Pakistan since 2016, leaving limited treatment options 5, 6. This makes culture and sensitivity testing increasingly critical rather than relying on empiric therapy alone.